Restoration of bFGF to physiological levels either by systemic administration or by in vivo gene transfer significantly augmented the number of endothelial cells with positive immunostaining for eNOS, corrected hypertension, and improved vasorelaxation [40]. The gene discussed is NOS3; the disease is Hypertension.